Genertec Universal Medical Group Company Limited

SEHK:2666 Stok Raporu

Piyasa değeri: HK$9.4b

Genertec Universal Medical Group Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Wang Wenbing

İcra Kurulu Başkanı

CN¥4.5m

Toplam tazminat

CEO maaş yüzdesi32.2%
CEO görev süresi7.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi1.6yrs
Yönetim Kurulu ortalama görev süresi2.4yrs

Son yönetim güncellemeleri

Recent updates

Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Oct 09
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

May 10
Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Feb 05
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Jun 08
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 08
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 31
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Aug 20
Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Apr 19
Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Mar 10
Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Feb 19
Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

Feb 01
Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 11
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Dec 21
What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Nov 30
Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

CEO Tazminat Analizi

Wang Wenbing'un ücretlendirmesi Genertec Universal Medical Group'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥4mCN¥1m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥4mCN¥1m

CN¥2b

Sep 30 2022n/an/a

CN¥2b

Jun 30 2022n/an/a

CN¥2b

Mar 31 2022n/an/a

CN¥2b

Dec 31 2021CN¥2mCN¥731k

CN¥2b

Tazminat ve Piyasa: Wang's total compensation ($USD630.35K) is about average for companies of similar size in the Hong Kong market ($USD496.15K).

Tazminat ve Kazançlar: Wang's compensation has been consistent with company performance over the past year.


CEO

Wang Wenbing (50 yo)

7.8yrs

Görev süresi

CN¥4,489,000

Tazminat

Mr. Wang Wenbing is General Manager of China Universal Leasing Co., Ltd since October 14, 2021. He has been Deputy General Manager of Genertec Universal Medical Group Company Limited (formerly known as Uni...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Wang Wenbing
CEO & Executive Director7.8yrsCN¥4.49mVeri yok
Lin Wang
Executive Director1.3yrsCN¥965.00kVeri yok
Shisu Chen
Executive Chairmanless than a yearVeri yokVeri yok
Shinan Wang
Chief Accounting Officer & General Counsel1.6yrsVeri yokVeri yok
Feng Qingming
Chief Medical Officerno dataVeri yokVeri yok
Wai Kam Ng
Company Secretary4.9yrsVeri yokVeri yok

1.6yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: 2666's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Wang Wenbing
CEO & Executive Director3.2yrsCN¥4.49mVeri yok
Lin Wang
Executive Director1.3yrsCN¥965.00kVeri yok
Shisu Chen
Executive Chairmanless than a yearVeri yokVeri yok
Yinquan Li
Independent Non-Executive Director9.4yrsCN¥363.00kVeri yok
Zhiming Xu
Independent Non-executive Director2.4yrsCN¥363.00kVeri yok
Kai Kong Chan
Non-Executive Vice-Chairman2.4yrsVeri yok0.0016%
HK$ 149.2k
Siu Lui Chow
Independent Non-Executive Director9.4yrsCN¥363.00kVeri yok
Ming Xu
Non-Executive Director2.4yrsVeri yokVeri yok
Chaoyin Tong
Non-Executive Director3.5yrsVeri yokVeri yok
Hiu Fung Chan
Independent Non-executive Director2.4yrsCN¥363.00kVeri yok
Ziyang Zhu
Non-Executive Director3.3yrsVeri yokVeri yok

2.4yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2666's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.